堃博医疗-B发布中期业绩 净亏损779.2万美元 同比收窄1.9%

Core Viewpoint - Kubo Medical-B (02216) reported a significant decline in revenue for the six months ending June 30, 2025, indicating challenges in the business environment [1] Financial Performance - The company's revenue was $1.652 million, representing a year-on-year decrease of 55.4% [1] - Net loss for the period was $7.792 million, which is a slight improvement of 1.9% compared to the previous year [1] - Gross profit stood at $1.214 million, down 58.9% year-on-year [1]